Increased splenic fluorodeoxyglucose uptake in a patient with granulomatous angitis

Internal Medicine

Volumn 46, Issue 12, 2007, Pages 909-911

  Maruoka, Hiroshi ^a   Koga, Takeharu ^a   Takeo, Masaaki ^a   Honda, Seiyo ^a   Yuge, Kentaro ^a   Fukuda, Takaaki ^a   Aizawa, Hisamichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ANCA associated vasculities; FDG PET; Spleen

Indexed keywords

ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; FLUORODEOXYGLUCOSE F 18; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; SOLUBLE INTERLEUKIN 2 RECEPTOR;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ENZYME BLOOD LEVEL; FEMALE; FEVER; GRANULOMATOUS VASCULITIS; HUMAN; IMAGE DISPLAY; LYMPHOMA; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PROTEIN BLOOD LEVEL; SPLENECTOMY; SPLENOMEGALY; TACHYCARDIA; WEIGHT REDUCTION;

FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SPLEEN; SPLENOMEGALY; TREATMENT OUTCOME; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 34547879627     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0098     Document Type: Article

References (12)

1. Love C, Tomas MB, Tronco GG, Palestro CJ. FDG PET of infection and inflammation. Radiographics 25: 1357-1368, 2005.
2. Blockmans D, Knockaert D, Maes A, et al. Clinical value of [(18) F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 32: 191-196, 2001.
3. Wong CL, Fulham MJ. Increased splenic FDG uptake on PET in beta-thalassemia. Clin Nucl Med 29: 266-267, 2004.
4. Burrell SC, Fischman AJ. Myelofibrosis on F-18 FDG PET Imaging. Clin Nucl Med 30: 674, 2005.
5. Sugawara Y, Zasadny KR, Kison PV, Baker LH, Wahl RL. Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results. J Nucl Med 40: 1456-1462, 1999.
6. Lie JT. Disseminated visceral giant cell arteritis: histopathologic description and differentiation from other granulomatous vasculitides. Am J Clin Pathol 69: 299-305, 1978.
7. Doyle MK. Cuellar Drug-induced vasculitis. ML Expert Opin Drug Saf 2: 401-409, 2003.
8. Kagata Y, Matsubara O, Ogata S, Lie JT, Mark EJ. Infantile disseminated visceral giant cell arteritis presenting as sudden infant death. Pathol Int 49: 226-230, 1999.
9. Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodcoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 36: 1301-1306, 1995.
10. Hara M, Goodman PC, Leder RA. FDG-PET finding in early-phase Takayasa arteritis. J Stroobants S, Maes A, Mortel Comput Assist Tomogr 23: 16-18, 1999.
11. Blockmans D, Mans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 108: 246-249, 2000.
12. Beggs AD, Hain SF. F-18 FDG-positron emission tomographic scanning and Wegener's granulomatosis. Clin Nucl Med Oct 27 (10): 705-706, 2002.